Expression of mRNA for chemokines and chemokine receptors in tissues of the myometrium and uterine leiomyoma

被引:0
作者
K. A. Syssoev
N. V. Kulagina
A. B. Chukhlovin
E. B. Morozova
Areg A. Totolian
机构
[1] I. P. Pavlov St. Petersburg State Medical University,
[2] Medical Academy of Postgraduate Education,undefined
来源
Bulletin of Experimental Biology and Medicine | 2008年 / 145卷
关键词
chemokines; chemokine receptors; mRNA; uterine leiomyoma; myometrium;
D O I
暂无
中图分类号
学科分类号
摘要
Tissues samples of leiomyoma and myometrium obtained intraoperatively were analyzed. For evaluation of the synthesis of MIP-1α, MIP-1β, RANTES, eotaxin, eotaxin-2, interleukin-8, CCR1, CCR3, CCR5, CXCR1, and CXCR2, mRNA isolated from tissues samples of leiomyoma and myometrium was subjected to reverse transcription-PCR and assayed by a semiquantitative method (relative to β-actin). The content of eotaxin, MIP-1α, MIP-1β, and CCR5 mRNA in leiomyoma tissue was lower than in the myometrium. The concentration of MIP-1β, CCR5, and eotaxin mRNA in common leiomyoma was much lower than in the myometrium. Eotaxin mRNA expression in myometrial tissue of patients with single nodes was much higher than in those with multiple nodes. Moreover, expression of eotaxin mRNA in common leiomyoma was higher than in proliferating leiomyoma. The concentration of mRNA for interleukin-8 in leiomyoma tissue, as well as the content of mRNA for MIP-1α and CCR3 in myometrial tissue increased in patients with submucosal nodes (as distinct from nodes of another location). A direct correlation was revealed between the size of the uterus and concentration of mRNA for interleukin-8 and MIP-1β in myometrial tissue. The concentration of mRNA for MIP-1α and MIP-1β in leiomyoma tissue negatively correlated with the size of the uterus (maximum size of the node) and duration of leiomyoma, respectively. Our results indicate that chemokines play an important role in the pathogenesis of uterine leiomyoma.
引用
收藏
页码:84 / 89
页数:5
相关论文
共 44 条
[1]  
Morozova E. B.(2005)undefined Zh. Akusherstva Zhenskikh Boleznei 54 54-59
[2]  
Chukhlovin A. B.(2006)undefined Med. Immunol. 8 547-556
[3]  
Totolian Areg. A.(1999)undefined Br. J. Obstet. Gynaecol. 106 725-730
[4]  
Syssoev K. A.(2003)undefined Mol. Hum. Reprod. 9 189-198
[5]  
Kulagina N. V.(2005)undefined Hum. Reprod. 20 1439-1446
[6]  
Totolian A. A.(1997)undefined J. Clin. Endocrinol. Metab. 82 1621-1628
[7]  
Akiyama M.(2003)undefined J. Clin. Endocrinol. Metab. 88 1809-1814
[8]  
Okabe H.(2004)undefined Hum. Reprod. Update 10 207-220
[9]  
Takakura K.(2005)undefined J. Immunol. 174 6023-6029
[10]  
Dominguez F.(2001)undefined Am. J. Obstet. Gynecol. 184 559-566